These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
102 related articles for article (PubMed ID: 120869)
41. Normobaric oxygen as a sensitizer in radiotherapy for advanced head and neck cancer. Zajusz A; Maciejewski B; Hliniak A Neoplasma; 1995; 42(3):137-40. PubMed ID: 7637824 [TBL] [Abstract][Full Text] [Related]
42. Methotrexate and radiation therapy in the treatment of advanced head and neck tumors. Knowlton AH; Percarpio B; Bobrow S; Fischer JJ Radiology; 1975 Sep; 116(3):709-12. PubMed ID: 807952 [TBL] [Abstract][Full Text] [Related]
43. Management of stages III and IV head and neck cancer. Mendenhall WM; Parsons JT Int J Radiat Oncol Biol Phys; 1990 Dec; 19(6):1627-8. PubMed ID: 2152342 [No Abstract] [Full Text] [Related]
44. Survival Patterns in Elderly Head and Neck Squamous Cell Carcinoma Patients Treated With Definitive Radiation Therapy. Sommers LW; Steenbakkers RJHM; Bijl HP; Vemer-van den Hoek JGM; Roodenburg JLN; Oosting SF; Halmos GB; de Rooij SE; Langendijk JA Int J Radiat Oncol Biol Phys; 2017 Jul; 98(4):793-801. PubMed ID: 28476434 [TBL] [Abstract][Full Text] [Related]
45. Radiotherapy of the metastatic head and neck tumors with inhalation of the mixed gas 95% O2 and 5% CO2 without prophylactic irradiation. Kumasawa A; Iino Y; Sato Y; Inoue K Jpn J Exp Med; 1978 Oct; 48(5):463-6. PubMed ID: 748622 [No Abstract] [Full Text] [Related]
46. Incidence of small lymph node metastases with evidence of extracapsular extension: clinical implications in patients with head and neck squamous cell carcinoma. Ghadjar P; Simcock M; Schreiber-Facklam H; Zimmer Y; Gräter R; Evers C; Arnold A; Wilkens L; Aebersold DM Int J Radiat Oncol Biol Phys; 2010 Dec; 78(5):1366-72. PubMed ID: 20231070 [TBL] [Abstract][Full Text] [Related]
47. Enhanced control by radiotherapy of cervical lymph node metastases arising from nasopharyngeal carcinoma compared with nodal metastases from other head and neck squamous cell carcinomas. Chow E; Payne D; Keane T; Panzarella T; Izard MA Int J Radiat Oncol Biol Phys; 1997 Aug; 39(1):149-54. PubMed ID: 9300749 [TBL] [Abstract][Full Text] [Related]
48. Radiotherapy and hyperbaric oxygen in head and neck cancer. Final report of first controlled clinical trial. Henk JM; Kunkler PB; Smith CW Lancet; 1977 Jul; 2(8029):101-3. PubMed ID: 69191 [TBL] [Abstract][Full Text] [Related]
49. Squamous cell carcinoma of the head and neck: management after excisional biopsy of a solitary metastatic neck node. Mack Y; Parsons JT; Mendenhall WM; Stringer SP; Cassisi NJ; Million RR Int J Radiat Oncol Biol Phys; 1993 Mar; 25(4):619-22. PubMed ID: 8454479 [TBL] [Abstract][Full Text] [Related]
50. Mitomycin C as an adjunct to postoperative radiation therapy in squamous cell carcinoma of the head and neck: results from two randomized clinical trials. Haffty BG; Son YH; Sasaki CT; Papac R; Fischer D; Rockwell S; Sartorelli A; Fischer JJ Int J Radiat Oncol Biol Phys; 1993 Sep; 27(2):241-50. PubMed ID: 7691784 [TBL] [Abstract][Full Text] [Related]
51. Late results of a trial of hyperbaric oxygen and radiotherapy in head and neck cancer: a rationale for hypoxic cell sensitizers? Henk JM Int J Radiat Oncol Biol Phys; 1986 Aug; 12(8):1339-41. PubMed ID: 3531112 [TBL] [Abstract][Full Text] [Related]
52. End stage palliative care of head and neck cancer: a case study. Shishodia NP; Divakar DD; Al Kheraif AA; Ramakrishnaiah R; Pathan AA; Parine NR; Chandroth SV; Purushothaman B Asian Pac J Cancer Prev; 2015; 16(3):1255-8. PubMed ID: 25735365 [TBL] [Abstract][Full Text] [Related]
54. A phase I/II study of the hypoxic cell sensitizer misonidazole as an adjunct to high fractional dose radiotherapy in patients with unresectable squamous cell carcinoma of the head and neck: a RTOG randomized study (#79-04). Lee DJ; Pajak TF; Stetz J; Order SE; Weissberg JB; Fischer JJ Int J Radiat Oncol Biol Phys; 1989 Feb; 16(2):465-70. PubMed ID: 2646255 [TBL] [Abstract][Full Text] [Related]
55. A randomised study of dietary intake in patients undergoing radiation therapy. Moriarty M; Moloney M; Mulgrew S; Daly L Ir Med J; 1981 Feb; 74(2):39-42. PubMed ID: 7014526 [No Abstract] [Full Text] [Related]
56. Evolution of the Radiation Therapy Oncology Group clinical trials for head and neck cancer. Fu KK; Cooper JS; Marcial VA; Laramore GE; Pajak TF; Jacobs J; Al-Sarraf M; Forastiere AA; Cox JD Int J Radiat Oncol Biol Phys; 1996 Jun; 35(3):425-38. PubMed ID: 8655364 [TBL] [Abstract][Full Text] [Related]
57. Five versus six fractions of radiotherapy per week for squamous-cell carcinoma of the head and neck (IAEA-ACC study): a randomised, multicentre trial. Overgaard J; Mohanti BK; Begum N; Ali R; Agarwal JP; Kuddu M; Bhasker S; Tatsuzaki H; Grau C Lancet Oncol; 2010 Jun; 11(6):553-60. PubMed ID: 20382075 [TBL] [Abstract][Full Text] [Related]
58. Increased recurrences using intensity-modulated radiation therapy in the postoperative setting. Turaka A; Li T; Sharma NK; Li L; Nicolaou N; Mehra R; Burtness B; Cohen RB; Lango MN; Horwitz EM; Ridge JA; Feigenberg SJ Am J Clin Oncol; 2010 Dec; 33(6):599-603. PubMed ID: 21063195 [TBL] [Abstract][Full Text] [Related]
59. Usefulness of tumor volumetry as a prognostic factor of survival in head and neck cancer. Kurek R; Kalogera-Fountzila A; Muskalla K; Dafni U; Schnabel T; Kober B; Röddiger S; Martin T; Fountzilas G; Zamboglou N Strahlenther Onkol; 2003 May; 179(5):292-7. PubMed ID: 12740655 [TBL] [Abstract][Full Text] [Related]
60. Ultrasonographic changes in malignant neck nodes during radiotherapy in head and neck squamous carcinoma. Correa P; Arya S; Laskar SG; Shrivastava SK; Dinshaw KA; Gupta T; Agarwal JP Australas Radiol; 2005 Apr; 49(2):113-8. PubMed ID: 15845046 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]